A myeloid program associated with COVID-19 severity is decreased by therapeutic blockade of IL-6 signaling https://www.medrxiv.org/content/10.1101/2022.11.07.22282049
QOTO: Question Others to Teach Ourselves An inclusive, Academic Freedom, instance All cultures welcome. Hate speech and harassment strictly forbidden.